NCBI Logo
GEO Logo
   NCBI > GEO > Accession DisplayHelp Not logged in | LoginHelp
GEO help: Mouse over screen elements for information.
          Go
Series GSE241602 Query DataSets for GSE241602
Status Public on May 03, 2024
Title Dynamic Chromatin Alteration Induces Oncogenic Hijacking by Nuclear Factor I Family Proteins for Medulloblastoma Progression
Organisms Homo sapiens; Mus musculus
Experiment type Expression profiling by high throughput sequencing
Summary The cancer-specific epigenome is the critical scaffold on which genetic programs work to positively promote cancer growth and progression. Understanding and appropriately disrupting this epigenome will lead to the discovery of new, more extensive and effective therapies in addition to conventional personalized medicine that relies on genomic mutations. However, the epigenomic changes during the process from normal cells to cancer formation as well as the molecules involved in the maintenance of the aberrant epigenome are still poorly characterized, and the development of epigenome-based therapeutics is therefore undeniably stagnant. To address this issue, we here focus on SHH-subgroup medulloblastoma, a representative pediatric brain tumor for which we developed a reliable mouse model to capture the epigenomic changes that cerebellar granule cells, the cells of origin, undergo during tumorigenesis. By comparing the epigenomes of the different stages of transforming cells, we identified NFI family of developmental factors as oncogenic regulators in the epigenome of pre-cancerous and cancerous cells, which they also contribute to maintain. Furthermore, we report pharmacological experiments demonstrating that inhibition of NFIB methylation blocks tumor growth and increases sensitivity to molecularly targeted drugs by disrupting the cancer epigenome. Thus, this study is a unique example of how epigenomic studies of cancer have led directly to therapeutic insights, and similar approaches in various cancers would accelerate the establishment of novel therapies.
 
Overall design To identify the transcriptional targets of NFIA and NFIB in the context of Sonic Hedgehog medulloblastoma (SHH-MB), we performed knockdown of these genes using shRNAs and checked which genes were differentially expressed. The knockdown was performed in two human SHH-MB PDXs and on cultured murine SHH-MB cells derived from a spontaneous SHH-MB mouse model, in order to allow cross-species comparisons. The data from RNA-seq were also crossed and integrated with ATAC-seq and CUT&Tag data to identify direct targets of NFIA and NFIB.
 
Citation missing Has this study been published? Please login to update or notify GEO.
Submission date Aug 23, 2023
Last update date May 03, 2024
Contact name Jacob Torrejon Diaz
E-mail(s) jacob.torrejon-diaz@curie.fr
Organization name Curie Institute
Street address 26 Rue d'Ulm
City Paris
ZIP/Postal code 75005
Country France
 
Platforms (2)
GPL24247 Illumina NovaSeq 6000 (Mus musculus)
GPL24676 Illumina NovaSeq 6000 (Homo sapiens)
Samples (30)
GSM7731549 BT084, PDX, NC, biol rep1
GSM7731550 BT084, PDX, shNFIA, biol rep1
GSM7731551 BT084, PDX, shNFIB, biol rep1
Relations
BioProject PRJNA1008757

Download family Format
SOFT formatted family file(s) SOFTHelp
MINiML formatted family file(s) MINiMLHelp
Series Matrix File(s) TXTHelp

Supplementary file Size Download File type/resource
GSE241602_raw_counts_PDXs_KD_NFI.txt.gz 1.4 Mb (ftp)(http) TXT
GSE241602_raw_counts_VDR_KD_NFI.txt.gz 815.9 Kb (ftp)(http) TXT
SRA Run SelectorHelp
Raw data are available in SRA
Processed data are available on Series record

| NLM | NIH | GEO Help | Disclaimer | Accessibility |
NCBI Home NCBI Search NCBI SiteMap